Beneficial effects of the phytocannabinoid Δ9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease
The antioxidant and CB2 receptor agonist properties of Δ9-tetrahydrocannabivarin (Δ9-THCV) afforded neuroprotection in experimental Parkinson's disease (PD), whereas its CB1 receptor antagonist profile at doses lower than 5 mg/kg caused anti-hypokinetic effects. In the present study, we investigated...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020-07-01
|
| Col·lecció: | Neurobiology of Disease |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S0969996120301674 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|